- $938.34m
- $895.51m
- $81.39m
U.S. STOCKS ON THE MOVE-MP Materials, Five9, Alphabet
U.S. STOCKS ON THE MOVE-MercadoLibre, CrowdStrike Holdings, Protagonist Therapeutics
MeiraGTx rises on positive data from genetic eye condition treatment
U.S. RESEARCH ROUNDUP-Cisco, Freshpet, Nvidia
MeiraGTx Holdings PLC reports results for the quarter ended September 30 - Earnings Summary
MeiraGTx Holdings PLC expected to post a loss of 52 cents a share - Earnings Preview
Brief: MeiraGTx Holdings Says Primary Study Objective Of Safety And Tolerability Was Met
Brief: MeiraGTx Announces Pricing Of Offering Of Ordinary Shares Led By Sanofi
Brief: MeiraGTx Q2 EPS USD -0.76
MeiraGTx Holdings PLC expected to post a loss of 40 cents a share - Earnings Preview
MeiraGTx Holdings PLC reports results for the quarter ended in March - Earnings Summary
MeiraGTx Holdings PLC expected to post a loss of 50 cents a share - Earnings Preview
MeiraGTx Holdings PLC reports results for the quarter ended in December - Earnings Summary
Factbox: Who are OpenAI's new board members?
MeiraGTx Holdings PLC expected to post a loss of 11 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Beyond, Cintas, Nike
MeiraGTx rises as JNJ buys drug for genetic blindness causing disease
Brief: Meiragtx Holdings PLC Files For Mixed Shelf Of Upto $250 Million- SEC Filing
Brief: MeiraGTx Announces Asset Purchase Agreement Involving its AAV-RPGR Collaboration for up to $415 Mln